Table 1 Characteristics of the couples and biological parameters of the IVF cycles used for the primary objective. Data are reported as means and standard deviations (SD). BMI body mass index, IVF in vitro fertilization, IU International Unit, PN pronuclei.

From: Biphasic (5–2%) oxygen concentration strategy significantly improves the usable blastocyst and cumulative live birth rates in in vitro fertilization

Parameter

Monophasic (5%) O2 strategy

Biphasic (5–2%) O2 strategy

p value

Couples (n)/cycles (n)

120/120

120/120

Women’s age (years)

33.5 ± 4.6

35.3 ± 4.4

< 0.01

Women’s BMI (kg/m2)

23.7 ± 4.3

23.8 ± 4.2

0.91

Men’s age (years)

36.4 ± 6.1

37.9 ± 6.1

0.06

Duration of infertility (months)

44.3 ± 29.1

43.7 ± 29.4

0.86

Total number of IVF cycles (n)

1.6 ± 0.9

2.7 ± 1.0

< 0.01

Number of women smoking (cigarettes/week)

25/120

50 ± 35

24/120

50 ± 35

1

1

Number of men smoking (cigarettes/week)

42/120

72 ± 39

42/120

75 ± 40

1

0.77

Primary dose of gonadotrophins (IU)

215.2 ± 82.9

234.2 ± 82.2

0.06

Total dose of gonadotrophins (IU)

2274.5 ± 979.1

2559.6 ± 1077.3

0.06

Duration of stimulation (days)

10.4 ± 1.5

10.8 ± 1.9

0.06

Retrieved oocytes (n)

10.9 ± 5.0

11.1 ± 6.0

0.86

Oocytes (n) inseminated or injected (IVF/ICSI)

247/843

219/860

0.18

2 PN embryos at day 1 (n)

5.7 ± 3.3

5.6 ± 3.4

0.52

Embryos at day 3 (n)

6.4 ± 3.7

6.2 ± 3.8

0.49

Total blastocyst rate (n, %)

44.4% (230/518)

54.8% (297/542)

0.049

Usable blastocyst rate (n, %)

21.8% (113/518)

32.8% (178/542)

0.002

Usable blastocyst rate at day 5 (n, %)

9.1% (47/518)

19.9% (108/542)

1.53 × 10–5

Usable blastocyst rate at day 6 (n, %)

12.7% (66/518)

12.9% (70/542)

0.94

  1. Data in bold indicate statistically significant results.